Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals
- PMID: 16449100
- PMCID: PMC1513138
- DOI: 10.1080/10550490500419169
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals
Abstract
A double-blind placebo-controlled crossover Phase I trial was conducted to assess the safety and tolerability of N-Acetylcysteine (NAC) in healthy, cocaine-dependent humans. Thirteen participants attended a three-day hospitalization in which they received placebo or NAC. Subjects were crossed over to receive the opposite medication condition during a second three-day hospitalization, which occurred the following week. Across placebo and NAC conditions, only mild side effects were noted, and the number of subjects reporting side effects did not differ. There were trends for a greater reduction in withdrawal symptoms and craving within the NAC condition. These preliminary results suggest that NAC is well tolerated in healthy, cocaine-dependent individuals and may reduce cocaine-related withdrawal symptoms and craving.
References
-
- Drug Abuse Warning Network . Office of Applied Studies; Washington, DC: 2001.
-
- Brust JC, Richter R. Stroke associated with cocaine abuse. New York State Journal of Medicine. 1977;77:1473–1475. - PubMed
-
- Schwartz KA, Cohen JA. Subarachnoid hemorrhage precipitated by cocaine snorting. Arch Neurol. 1984;41:705. - PubMed
-
- Cregler LL, Mark H. Medical complications of cocaine abuse. N Eng J Med. 1986;315:1495–1500. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
